The AMAG chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the AMAG chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.
The AMAG stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.
|View AMAG Detailed Price Forecast - CNN Money||View AMAG Detailed Summary - Google Finance|
|View AMAG Detailed Summary - Yahoo! Finance||View AMAG Stock Research & Analysis - Zacks.com|
|View AMAG Trends & Analysis - Trade-Ideas||View AMAG Major Holders - Barrons|
|View AMAG Call Transcripts - NASDAQ||View AMAG Breaking News & Analysis - Seeking Alpha|
|View AMAG Annual Report - CompanySpotlight.com||View AMAG OTC Short Report - OTCShortReport.com|
|View AMAG Fundamentals - TradeKing||View AMAG SEC Filings - Bar Chart|
|View Historical Prices for AMAG - The WSJ||View Performance/Total Return for AMAG - Morningstar|
|View the Analyst Estimates for AMAG - MarketWatch||View the Earnings History for AMAG - CNBC|
|View the AMAG Earnings - StockMarketWatch||View AMAG Buy or Sell Recommendations - MacroAxis|
|View the AMAG Bullish Patterns - American Bulls||View AMAG Short Pain Metrics - ShortPainBot.com|
|View AMAG Stock Mentions - StockTwits||View AMAG Stock Mentions - PennyStockTweets|
|View AMAG Stock Mentions - Twitter||View AMAG Investment Forum News - Investor Hub|
|View AMAG Stock Mentions - Yahoo! Message Board||View AMAG Stock Mentions - Seeking Alpha|
|View Insider Transactions for AMAG - SECform4.com||View Insider Transactions for AMAG - Insider Cow|
|View AMAG Major Holdings Summary - CNBC||View Insider Disclosure for AMAG - OTC Markets|
|View Insider Transactions for AMAG - Yahoo! Finance||View Institutional Holdings for AMAG - NASDAQ|
|View AMAG Stock Insight & Charts - FinViz.com||View AMAG Investment Charts - StockCharts.com|
|View AMAG Stock Overview & Charts - BarChart||View AMAG User Generated Charts - Trading View|
ETFs with exposure to AMAG Pharmaceuticals, Inc. : December 12, 2017
Posted on Tuesday December 12, 2017
Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to AMAG Pharmaceuticals, Inc. Here are 5 ETFs with the largest exposure to AMAG-US. Comparing the performance and risk of AMAG Pharmaceuticals, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)
Factors of Influence in 2018, Key Indicators and Opportunity within Xilinx, J.B. Hunt Transport Services, Southern, FirstEnergy, AMAG Pharmaceuticals, and Galectin Therapeutics — New Research Emphasizes Economic Growth
Posted on Friday December 01, 2017
NEW YORK, Dec. 01, 2017-- In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of ...
Edited Transcript of AMAG earnings conference call or presentation 2-Nov-17 12:00pm GMT
Posted on Friday November 24, 2017
Q3 2017 AMAG Pharmaceuticals Inc Earnings Call
Palatin Technologies Announces Signing of Licensing Agreement with Kwangdong Pharmaceutical for Republic of Korea
Posted on Tuesday November 21, 2017
"Palatin") announced today that it has entered into a collaboration and license agreement with Kwangdong Pharmaceutical Co., Ltd. ("Kwangdong"), for exclusive rights to develop and commercialize bremelanotide for female sexual dysfunction (FSD) indications in the Republic of Korea. Kwangdong, based in Seoul, Korea, is a leading Korean pharmaceutical company with annual sales of approximately $919 million in 2016. "We are extremely pleased to have Kwangdong as our partner for bremelanotide in Korea," stated Carl Spana, Ph.D., President and CEO of Palatin.